60% off Profit Pro - Limited Time Offer!
Belluscura Plc
BELL · LSEDay Range
52 Week Range
Market Cap
20.07MGBP
About
General Information
Type
Common Stock
Exchange
LSE
Currency Code
GBX
Currency Name
Pence sterling
Country Name
UK
Country ISO
GB
ISIN
-
CUSIP
-
Sector
Healthcare
Industry
Medical Devices
Fiscal Year End
December
IPO date
-
Updated At
-
Highlights
PE Ratio
-
PEG Ratio
-
Book Value
0.12
Dividend Share
-
Dividend Yield
-
Earnings Share
-0.1
Wall Street Target Price
36.3567
EPS Estimate Current Year
-0.058
EPS Estimate Next Year
0.004
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Profitability
Revenue TTM
1,804,945
Gross Profit TTM
68,105
EBITDA
-16,902,896
Profit Margin
0.00%
Return On Assets TTM
-43.53%
Return On Equity TTM
-85.01%
Revenue Per Share TTM
0.012
Qtly Revenue Growth YOY
267.50%
Diluted Eps TTM
-0.1
Qtly Earnings Growth YOY
0.00%
Valuation
Trailing PE
0.00
Forward PE
11
Price Sales TTM
8.8639
Price Book MRQ
1.0663
Enterprise Value Revenue
10
Enterprise Value EBITDA
-6
Peers analysis
- POLXPolarean Imaging Plc
1.30
1.96% - SNSmith & Nephew PLC
986.00
0.94% - NCYTNovacyt
49.80
0.61% - IUGIntelligent Ultrasound Group PLC
12.75
0.39% - EKFEKF Diagnostics Holdings Plc
27.00
0.37%
- IHCInspiration Healthcare Group PLC
12.50
0.00% - MXCTMaxCyte Inc
327.00
0.00% - NIOXNIOX Group PLCNI
63.20
0.00% - RUARua Life Sciences PLC
11.00
0.00% - CREOCreo Medical Group PLC
19.00
-1.30%
